Literature DB >> 7362664

Measurement of patient outcome in arthritis.

J F Fries, P Spitz, R G Kraines, H R Holman.   

Abstract

A structure for representation of patient outcome is presented, together with a method for outcome measurement and validation of the technique in rheumatoid arthritis. The paradigm represents outcome by five separate dimensions: death, discomfort, disability, drug (therapeutic) toxicity, and dollar cost. Each dimension represents an outcome directly related to patient welfare. Quantitation of these outcome dimensions may be performed at interview or by patient questionnaire. With standardized, validated questions, similar scores are achieved by both methods. The questionnaire technique is preferred since it is inexpensive and does not require interobserver validation. These techniques appear extremely useful for evaluation of long term outcome of patients with rheumatic diseases.

Entities:  

Mesh:

Year:  1980        PMID: 7362664     DOI: 10.1002/art.1780230202

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  1026 in total

1.  Cyclicity in incidence variations of meningococcal infections in Bulgaria is similar to that of solar activity.

Authors:  B D Dimitrov
Journal:  Cent Eur J Public Health       Date:  2000-05       Impact factor: 1.163

2.  Quality of life as an instrument for need assessment and outcome assessment of health care in chronic patients.

Authors:  G A van den Bos; A H Triemstra
Journal:  Qual Health Care       Date:  1999-12

Review 3.  Subjective outcome measurement--a primer.

Authors:  M P Tully; J A Cantrill
Journal:  Pharm World Sci       Date:  1999-06

4.  Health Assessment Questionnaire modifications: is standardisation needed?

Authors:  M M Zandbelt; P M Welsing; A M van Gestel; P L van Riel
Journal:  Ann Rheum Dis       Date:  2001-09       Impact factor: 19.103

5.  Radiographic progression in rheumatoid arthritis: does it reflect outcome? Does it reflect treatment?

Authors:  D van der Heijde
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 6.  Benchmarking and the percentile assessment of RA: adding a new dimension to rheumatic disease measurement.

Authors:  F Wolfe; H K Choi
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 7.  Effects of anakinra on clinical and radiological outcomes in rheumatoid arthritis.

Authors:  B Bresnihan
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

8.  Determinants of locomotor disability in people aged 55 years and over: the Rotterdam Study.

Authors:  E Odding; H A Valkenburg; H J Stam; A Hofman
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

9.  Validity and interpretability of the QuickDASH in the assessment of hand disability in rheumatoid arthritis.

Authors:  Fausto Salaffi; Marco Di Carlo; Marina Carotti; Sonia Farah
Journal:  Rheumatol Int       Date:  2018-12-03       Impact factor: 2.631

10.  Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis.

Authors:  Nick Bansback; Roberta Ara; Sue Ward; Aslam Anis; Hyon K Choi
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.